IFP Advisors’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $269 | Sell |
336
-25
| -7% | -$29 | ﹤0.01% | 4561 |
|
|
2025
Q4 | $469 | Sell |
361
-155
| -30% | -$191 | ﹤0.01% | 4298 |
|
|
2025
Q3 | $650 | Buy |
516
+482
| +1,418% | +$764 | ﹤0.01% | 4097 |
|
|
2025
Q2 | $70 | Buy |
+34
| New | +$69 | ﹤0.01% | 4776 |
|
|
2025
Q1 | – | Sell |
-35
| Closed | -$54 | – | 4499 |
|
|
2024
Q4 | $54 | Buy |
+35
| New | +$57 | ﹤0.01% | 4236 |
|
|
2023
Q4 | – | Sell |
-271
| Closed | -$279 | – | 3189 |
|
|
2023
Q3 | $279 | Buy |
+271
| New | +$386 | ﹤0.01% | 3164 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3962 |
|
|
2021
Q2 | – | Sell |
-200
| Closed | -$3.18K | – | 3679 |
|
|
2021
Q1 | $3K | Buy |
200
+158
| +376% | +$2.82K | ﹤0.01% | 2564 |
|
|
2020
Q4 | $1K | Buy |
+42
| New | +$730 | ﹤0.01% | 2763 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 3333 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 3196 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 3185 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 3191 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 3336 |
|
|
2019
Q1 | – | Sell |
-14
| Closed | – | – | 2817 |
|
|
2018
Q4 | $0 | Sell |
14
-225
| -94% | -$6.19K | ﹤0.01% | 3691 |
|
|
2018
Q3 | $8K | Buy |
239
+25
| +12% | +$931 | ﹤0.01% | 2971 |
|
|
2018
Q2 | $8K | Buy |
+214
| New | +$6.81K | ﹤0.01% | 3031 |
|
|
2017
Q1 | – | Sell |
-1
| Closed | – | – | 4052 |
|
|
2016
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 4046 |
|
|
2016
Q3 | $0 | Sell |
1
-11
| -92% | -$204 | ﹤0.01% | 3953 |
|
|
2016
Q2 | $0 | Buy |
+12
| New | +$234 | ﹤0.01% | 3923 |
|
|
2016
Q1 | – | Sell |
-11
| Closed | – | – | 2833 |
|
|
2015
Q4 | $0 | Buy |
+11
| New | +$294 | ﹤0.01% | 3758 |
|
Other funds holding HRTX
RCMNY
CC
O
VCIM
VCM
TC
TCM
PCM